Literature DB >> 1156542

Atopic disease and serum immunoglobulin-E.

H E Jones, J C Inouye, J L McGerity, C W Lewis.   

Abstract

Fifty-seven subjects, forty-three with various combinations of atopic disease and fourteen non-atopic controls, were studied using a battery of immediate skin test allergens and a radio-immunoassay for serum Immunoglobulin-E (IgE). The geometric mean serum IgE level (units/ml) was 50 in strictly nonatopic controls, 170 in atopic respiratory disease (ARD) patients, 320 in atopic dermatitis (AD) patients and 772 in those patients with both AD-ARD. The marked elevation of the serum IgE in the latter group was not associated with respiratory disease activity and not closely correlated with extent of the dermatitis, but may relate to patients with both AD-ARD being 'highly atopic'. Overall, there was no correlation between the serum IgE level and the frequency of positive skin tests. Compared to ARD patients, the serum of AD patients contained more IgE, yet they reacted significantly less frequently to common extrinsic allergens.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1156542     DOI: 10.1111/j.1365-2133.1975.tb03028.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  20 in total

Review 1.  Immunopathology of atopic dermatitis.

Authors:  D Y Leung
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Decreased expression of filaggrin in atopic skin.

Authors:  T Seguchi; C Y Cui; S Kusuda; M Takahashi; K Aisu; T Tezuka
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

Review 3.  Immunoregulatory abnormalities in atopic dermatitis.

Authors:  D Y Leung; R S Geha
Journal:  Clin Rev Allergy       Date:  1986-02

Review 4.  The atopic worker.

Authors:  A I Terr
Journal:  Clin Rev Allergy       Date:  1986-08

5.  The disease progression in the keratin 14 IL-4-transgenic mouse model of atopic dermatitis parallels the up-regulation of B cell activation molecules, proliferation and surface and serum IgE.

Authors:  L Chen; S-X Lin; L Overbergh; C Mathieu; L S Chan
Journal:  Clin Exp Immunol       Date:  2005-10       Impact factor: 4.330

Review 6.  [Application of humanized Anti-IgE antibodies (omalizumab). A new principle in the treatment of allergic diseases in ENT medicine].

Authors:  O Pfaar; L Klimek
Journal:  HNO       Date:  2007-12       Impact factor: 1.284

Review 7.  [Atopic patch test. Atopic eczema and allergy].

Authors:  U Darsow; J Ring
Journal:  Hautarzt       Date:  2003-10       Impact factor: 0.751

8.  Skin testing for allergy in children.

Authors: 
Journal:  Can Med Assoc J       Date:  1983-10-15       Impact factor: 8.262

9.  Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens.

Authors:  D Y Leung; R Harbeck; P Bina; R F Reiser; E Yang; D A Norris; J M Hanifin; H A Sampson
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

10.  An uncontrolled open pilot study to assess the role of dietary eliminations in reducing the severity of atopic dermatitis in infants and children.

Authors:  Sandipan Dhar; Rajib Malakar; Raghubir Banerjee; Saswati Chakraborty; Jayanti Chakraborty; Susmita Mukherjee
Journal:  Indian J Dermatol       Date:  2009       Impact factor: 1.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.